Abstract: A method for intermediary client reconnection to a preferred server in a high availability server cluster. The method includes monitoring a persistent connection of a logical connection to a preferred server to identify an unavailability of the preferred server, establishing a temporary persistent connection for the logical connection to an available server to replace an unavailable preferred server, prompting attempts to reconnect to the preferred server at intervals, and providing a connection switching pool and simultaneously re-establishing a persistent connection with the preferred server for the logical connection using the connection switching pool while terminating the temporary persistent connection to the available server. The connection switching pool and a main connection pool used by the persistent connection allow for simultaneously maintaining two connections to different servers in a same server cluster for the logical connection.

Abstract: A method, system, computer program product and a computer program for prioritizing queued tasks waiting to access a resource associated with a resource manager in an application server, wherein an incoming task received at the application server from a calling application may have a status indicating that the incoming task is in a final phase during which a response to the calling application is created, the method comprising: receiving the incoming task; identifying the status of the incoming task; in response to identifying that the status of the incoming task is in the final phase, placing the incoming task in a priority queue; analyzing any queued tasks waiting to access the resource in the priority queue and one or more other queues; and processing a queued task from the priority queue in preference to the one or more other queues.

Abstract: Disclosed are compounds suitable for enhancing cancer treatment, for example, a compound of formula (I): (I) wherein R1 is as defined herein. Also disclosed is a method of enhancing the response of cancer cells in a mammal to treatment with an apoptosis inducing ligand, a method of inducing apoptosis in cancer cells in a mammal, and a method of treating prostate cancer in mammal in need thereof comprising administration of a compound described herein.